Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 14;10(7):e0131965.
doi: 10.1371/journal.pone.0131965. eCollection 2015.

Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases

Affiliations

Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases

Susan T Paulukonis et al. PLoS One. .

Abstract

Introduction: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder. Estimates of survival from disease onset range from 20 to 48 months and have been generated using clinical populations or death records alone.

Methods: Data on a cohort of ALS cases diagnosed between 2009-2011 were collected as part of the Los Angeles and San Francisco Bay Area Metropolitan ALS Surveillance projects; death records 2009-2013 were linked to these confirmed cases to determine survival post diagnosis and factors associated with survival time.

Results: There were 618 cases identified and 283 of these died during the follow up time period. Median age at death was 64.3 years, and median survival time post-diagnosis was 2.6 years. Age at diagnosis and year of diagnosis were predictors of survival time in adjusted models; those diagnosed at age 80 or older had shorter survival than those diagnosed at age 50 or younger. Most (92%) had ALS noted as a cause of death.

Discussion: Survival post-diagnosis may be improved compared with previous reports. Age at diagnosis continues to be the strongest predictor of prognosis; recall case reporting bias may play a role in estimates of survival time.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: This project was funded by McKing Consulting Corporation through a contract funded by The federal Agency for Toxic Substances and Disease Registry funded McKing Consulting Corporation (Contract #200-2010-F-36614) to conduct this surveillance project on their behalf. McKing Consulting Corporation funded the Public Health Institute to conduct this project in California in coordination with the California Department of Public Health. Co-author WK is employed by McKing Consulting Corporation. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Survival Curves of Selected California County ALS Cases Post-Diagnosis, 2009–2013.
Kaplan Meier estimate survival curves of ALS cases post-diagnosis from Los Angeles County and selected San Francisco Bay Area counties, by age at diagnosis, last assigned El Escorial criteria, whether seen at referral center and year of diagnosis (diagnosed 2009–2011, deceased 2009–2013).

References

    1. Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler 2009;10(5–6): 310–23. 10.3109/17482960802566824 - DOI - PMC - PubMed
    1. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60(5): 813–9. - PubMed
    1. Gordon PH, Salachas F, Bruneteau G, Pradat PF, Lacomblez L, Gonzalez-Bermejo J, et al. Improving survival in a large French ALS center cohort. Journal of neurology 2012;259(9): 1788–92. 10.1007/s00415-011-6403-4 - DOI - PubMed
    1. Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2011;82(6): 623–7. 10.1136/jnnp.2010.224501 - DOI - PubMed
    1. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology 2007;68(5): 326–37. - PubMed

Publication types